HPD and ovarian cancer: Collectively, our results demonstrate that the metabolic enzyme HPD acts as a non‐canonical RBP to promote global mRNA translation efficiency in ovarian cancer, adding another dimension to the regulation of ovarian cancer development of HPD with moonlighting function.